These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2841493)

  • 41. Polyomavirus large T antigen zinc finger is not required for efficient cellular immortalization of primary rat embryo fibroblasts.
    Pilon AA; Mes-Masson AM
    Virus Res; 1996 Dec; 46(1-2):171-5. PubMed ID: 9029789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Truncated forms of the polyomavirus middle T antigen can substitute for the small T antigen in lytic infection.
    Templeton D; Simon S; Eckhart W
    J Virol; 1986 Jan; 57(1):367-70. PubMed ID: 3001358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The major site of tyrosine phosphorylation in polyomavirus middle T antigen is not required for transformation.
    Mes-Masson AM; Schaffhausen B; Hassell JA
    J Virol; 1984 Nov; 52(2):457-64. PubMed ID: 6092671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignant transformation of rat cells by the polyomavirus middle T gene.
    Gélinas C; Bastin M
    Virology; 1985 Oct; 146(2):233-45. PubMed ID: 2996218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant retroviruses that transduce individual polyoma tumor antigens: effects on growth and differentiation.
    Cherington V; Morgan B; Spiegelman BM; Roberts TM
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4307-11. PubMed ID: 3012562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serine 257 phosphorylation regulates association of polyomavirus middle T antigen with 14-3-3 proteins.
    Culleré X; Rose P; Thathamangalam U; Chatterjee A; Mullane KP; Pallas DC; Benjamin TL; Roberts TM; Schaffhausen BS
    J Virol; 1998 Jan; 72(1):558-63. PubMed ID: 9420259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cooperation of middle and small T antigens of polyomavirus in transformation of established fibroblast and epithelial-like cell lines.
    Noda T; Satake M; Yamaguchi Y; Ito Y
    J Virol; 1987 Jul; 61(7):2253-63. PubMed ID: 3035224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phosphoinositide kinase activity and transformation.
    Whitman M; Kaplan D; Cantley L; Roberts TM; Schaffhausen B
    Fed Proc; 1986 Oct; 45(11):2647-52. PubMed ID: 3019785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ability of a T-antigen transport-defective mutant of simian virus 40 to immortalize primary cells and to complement polyomavirus middle T in tumorigenesis.
    Vass-Marengo J; Ratiarson A; Asselin C; Bastin M
    J Virol; 1986 Sep; 59(3):655-9. PubMed ID: 3016328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deletion mapping of a short polyoma virus middle T antigen segment important for transformation.
    Nilsson SV; Tyndall C; Magnusson G
    J Virol; 1983 Apr; 46(1):284-7. PubMed ID: 6298462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transformation and radiosensitivity of human diploid skin fibroblasts transfected with SV40 T-antigen mutants defective in RB and P53 binding domains.
    Su LN; Little JB
    Int J Radiat Biol; 1992 Oct; 62(4):461-8. PubMed ID: 1357059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transformation of late passage insulin-like growth factor-I receptor null mouse embryo fibroblasts by SV40 T antigen.
    Spence SL; Shaffer AL; Staudt LM; Amde S; Manney S; Terry C; Weisz K; Nissley P
    Cancer Res; 2006 Apr; 66(8):4233-9. PubMed ID: 16618746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polyoma viral middle T-antigen is required for transformation.
    Mes AM; Hassell JA
    J Virol; 1982 May; 42(2):621-9. PubMed ID: 6283174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myristylation of pp60c-src is not required for complex formation with polyomavirus middle-T antigen.
    Wyss A; Kaech S; Ballmer-Hofer K
    J Virol; 1990 Oct; 64(10):5163-6. PubMed ID: 2168992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen.
    Freund R; Calderone A; Dawe CJ; Benjamin TL
    J Virol; 1991 Jan; 65(1):335-41. PubMed ID: 1845894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions of polyomavirus middle T with the SH2 domains of the pp85 subunit of phosphatidylinositol-3-kinase.
    Yoakim M; Hou W; Liu Y; Carpenter CL; Kapeller R; Schaffhausen BS
    J Virol; 1992 Sep; 66(9):5485-91. PubMed ID: 1380095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent progress in studies of polyomavirus tumour antigens.
    Magnusson G
    Exp Cell Res; 1985 Mar; 157(1):1-7. PubMed ID: 2982625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Down-regulation of cytokeratin 14 gene expression by the polyoma virus middle T antigen is dependent on c-Src association but independent of full transformation in rat liver nonparenchymal epithelial cells.
    Royal I; Raptis L; Druker BJ; Marceau N
    Cell Growth Differ; 1996 Jun; 7(6):737-43. PubMed ID: 8780887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector.
    Davidson D; Hassell JA
    J Virol; 1987 Apr; 61(4):1226-39. PubMed ID: 3029418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transformation by hamster polyomavirus: identification and functional analysis of the early genes.
    Goutebroze L; Feunteun J
    J Virol; 1992 Apr; 66(4):2495-504. PubMed ID: 1312640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.